Brain scans reveal Age's role in Alzheimer's plaque buildup

NCT ID NCT01095744

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study used special brain scans (PET imaging) to measure amyloid plaques in 60 people with Alzheimer's disease or related conditions like posterior cortical atrophy and logopenic progressive aphasia. The goal was to understand how age influences the amount of amyloid in the brain. Participants also had memory tests, MRI scans, and some had a spinal tap to measure proteins. The study is complete and aimed at gathering knowledge, not testing a treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease amyloidosis Cognitive Dysfunction logopenic progressive aphasia posterior cortical atrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Pitie Salpêtrière Hospital

    Paris, Île-de-France Region, 75651, France